Mayo Clinic College of Medicine and Science, Rochester, MN.
Intensive Care Unit, National Hospital of Pediatrics, Hanoi, Vietnam.
Pediatr Crit Care Med. 2019 Jul;20(7):e311-e318. doi: 10.1097/PCC.0000000000001980.
To assess the etiologies and outcomes of patients with secondary hemophagocytic lymphohistiocytosis in the PICU.
Prospective observational cohort study.
A single PICU at a pediatric tertiary hospital in Hanoi, Vietnam.
Pediatric patients meeting the criteria for secondary hemophagocytic lymphohistiocytosis.
None.
Between June 2017 and May 2018, 25 consecutive patients with a mean (SD) age of 23.3 months (21.6 mo) were included. Collected variables included etiologies of hemophagocytic lymphohistiocytosis and clinical and laboratory findings at admission. The Pediatric Index of Mortality 2 score at admission was calculated. Outcomes were death and multiple organ dysfunction. The severity of multiple organ dysfunction was assessed by the Pediatric Logistic Organ Dysfunction 2 score. The mean (SD) Pediatric Index of Mortality 2 predicted mortality rate was 5.6% (7.6%). Cytomegalovirus and Epstein-Barr virus coinfections (60%) were the most common suspected etiology of hemophagocytic lymphohistiocytosis. Other etiologies included Epstein-Barr virus sole infections (20%), cytomegalovirus sole infections (16%), and one unknown cause (4%). Multiple organ dysfunction (excluding hematologic failure) was found in 22 patients (88%) with death occurring in 14 patients (56%). The mean (SD) Pediatric Logistic Organ Dysfunction 2 predicted mortality rate among patients with multiple organ dysfunction was 11.9% (11.2%). Despite having lower Pediatric Index of Mortality 2 predicted mortality rates at admission, Epstein-Barr virus-cytomegalovirus coinfection cases with multiple organ dysfunction had slightly greater Pediatric Logistic Organ Dysfunction 2 predicted mortality rates than Epstein-Barr virus sole infection cases with multiple organ dysfunction: 12.2% (10.5%) versus 11.3% (11.0%). However, these rates were lower than cytomegalovirus sole infection cases with multiple organ dysfunction (14.4% [16.3%]). Area under the curve values for Pediatric Index of Mortality 2 and Pediatric Logistic Organ Dysfunction 2 were 0.74 (95% CI, 0.52-0.95) and 0.78 (95% CI, 0.52-1.00), respectively, suggesting that both scales were fair to good at predicting mortality.
Viral infections, particularly Epstein-Barr virus-cytomegalovirus coinfections, were a common cause of secondary hemophagocytic lymphohistiocytosis. The implication of these coinfections on the clinical course of hemophagocytic lymphohistiocytosis needs to be delineated.
评估 PIC U 中继发性噬血细胞性淋巴组织细胞增生症患者的病因和结局。
前瞻性观察队列研究。
越南河内一家儿科三级医院的一个单一 PIC U。
符合继发性噬血细胞性淋巴组织细胞增生症标准的儿科患者。
无。
2017 年 6 月至 2018 年 5 月,连续纳入 25 例平均(SD)年龄为 23.3 个月(21.6 月)的患者。收集的变量包括噬血细胞性淋巴组织细胞增生症的病因以及入院时的临床和实验室发现。入院时计算小儿死亡率 2 评分。结局为死亡和多器官功能障碍。通过儿科逻辑器官功能障碍 2 评分评估多器官功能障碍的严重程度。小儿死亡率 2 预测死亡率的平均值(SD)为 5.6%(7.6%)。巨细胞病毒和 Epstein-Barr 病毒合并感染(60%)是噬血细胞性淋巴组织细胞增生症最常见的疑似病因。其他病因包括单纯 Epstein-Barr 病毒感染(20%)、单纯巨细胞病毒感染(16%)和 1 例不明原因(4%)。22 例(88%)患者存在多器官功能障碍(不包括血液系统衰竭),其中 14 例(56%)死亡。在有多器官功能障碍的患者中,儿科逻辑器官功能障碍 2 预测死亡率的平均值(SD)为 11.9%(11.2%)。尽管入院时小儿死亡率 2 预测死亡率较低,但巨细胞病毒-Epstein-Barr 病毒合并感染伴多器官功能障碍的患儿,儿科逻辑器官功能障碍 2 预测死亡率略高于单纯 Epstein-Barr 病毒感染伴多器官功能障碍的患儿:12.2%(10.5%)比 11.3%(11.0%)。然而,这些比率低于单纯巨细胞病毒感染伴多器官功能障碍的患者(14.4%[16.3%])。小儿死亡率 2 和儿科逻辑器官功能障碍 2 的曲线下面积值分别为 0.74(95%CI,0.52-0.95)和 0.78(95%CI,0.52-1.00),表明这两种量表在预测死亡率方面均为中等至良好。
病毒感染,特别是 Epstein-Barr 病毒-巨细胞病毒合并感染,是继发性噬血细胞性淋巴组织细胞增生症的常见病因。这些合并感染对噬血细胞性淋巴组织细胞增生症临床过程的影响需要加以阐明。